DeepMammo, IBM, Accenture and Novartis expert speakers at AIXA FOR SCIENCE: how can AI support clinical workflows and cancer diagnosis.
![](https://www.aigeamedical.com/wp-content/uploads/2022/02/AIXA-1024x507.jpg)
How can artificial intelligence support clinical processes and mainly digital diagnostics?How can diagnostic data be used to teach artificial intelligence-based platforms?How, in the entire workflow of a radiological diagnosis, from the creation of medical record to acquisition, and processing up to the communication, is it possible to use artificial intelligence based tools? Our CEO Carlo […]
DeepMammo selected by BioUpper
![](https://www.aigeamedical.com/wp-content/uploads/2022/02/BioUpper-800x500_c-768x480-1.jpg)
We are proud to announce that DeepMammo, the disruptive AI solution for early breast cancer detection, has been selected by BioUpper. We can’t wait to get into the empowerment go-to-market phase, that will start in the next few weeks.DeepMammo was selected as one of 10 highest value projects, from over 117 applications collected. BioUpper is […]